Enamine, a leading integrated drug discovery contract research organization (CRO) has today announced its participation in an open-science collaboration with Variational AI and the Agora Open Science ...
Enamine’s agile IDD Platform of Computer-aided Drug Design (CADD), together with AI/ML approaches, innovative medicinal chemistry, and preclinical biology, including its capabilities in guiding ...
Enamine’s Target-Agnostic Expertise in Biology, Drug Design, and Medicinal Chemistry Advances EMUNO Therapeutics Pipeline KYIV, UKRAINE, January 22, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results